CD24 and esophageal cancer: Our observations demonstrate that administration of the chemotherapeutic 5-FU leads to an increase in CD24 marker expression in esophageal adenocarcinoma cell lines, which may be related to the stem cell phenotype, as suggested by its increased expression in esophageal cancer spheres.